Zero-fluoroscopy Approach Versus Fluoroscopic Approach for the Ablation of Paroxysmal Supraventricular Tachycardia

NACompletedINTERVENTIONAL
Enrollment

3,060

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

February 28, 2018

Study Completion Date

December 31, 2018

Conditions
Paroxysmal Supraventricular Tachycardia
Interventions
DEVICE

Zero-fluoroscopic ablation

Catheter ablation will be performed under the guidance of Ensite NavX and without the use of fluoroscopy.

DEVICE

Conventional fluoroscopic ablation

Catheter ablation will be performed under the guidance of Ensite NavX plus fluoroscopy.

Trial Locations (1)

430030

Tongji Hospital, Wuhan

All Listed Sponsors
collaborator

Chinese Academy of Medical Sciences, Fuwai Hospital

OTHER

collaborator

First Affiliated Hospital, Sun Yat-Sen University

OTHER

collaborator

Xiangyang Central Hospital

OTHER

collaborator

First Affiliated Hospital of Guangxi Medical University

OTHER

collaborator

Guangdong Provincial People's Hospital

OTHER

collaborator

Morristown Memorial Hospital

OTHER

collaborator

Beijing Anzhen Hospital

OTHER

collaborator

Ningbo No. 1 Hospital

OTHER

lead

Tongji Hospital

OTHER

NCT03042078 - Zero-fluoroscopy Approach Versus Fluoroscopic Approach for the Ablation of Paroxysmal Supraventricular Tachycardia | Biotech Hunter | Biotech Hunter